Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · IEX Real-Time Price · USD
14.11
-0.25 (-1.74%)
Apr 19, 2024, 4:00 PM EDT - Market closed
CNCR Holdings List
As of Apr 16, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GERN | Geron Corporation | 2.78% |
2 | ACRV | Acrivon Therapeutics, Inc. | 2.54% |
3 | ELVN | Enliven Therapeutics, Inc. | 2.20% |
4 | JANX | Janux Therapeutics, Inc. | 1.82% |
5 | NUVB | Nuvation Bio Inc. | 1.75% |
6 | TSVT | 2seventy bio, Inc. | 1.67% |
7 | RVMD | Revolution Medicines, Inc. | 1.54% |
8 | PRLD | Prelude Therapeutics Incorporated | 1.50% |
9 | LYEL | Lyell Immunopharma, Inc. | 1.48% |
10 | ACET | Adicet Bio, Inc. | 1.45% |
11 | NRIX | Nurix Therapeutics, Inc. | 1.42% |
12 | MGNX | MacroGenics, Inc. | 1.41% |
13 | MRK | Merck & Co., Inc. | 1.41% |
14 | ITOS | iTeos Therapeutics, Inc. | 1.41% |
15 | DAWN | Day One Biopharmaceuticals, Inc. | 1.40% |
16 | CGEM | Cullinan Oncology, Inc. | 1.39% |
17 | YMAB | Y-mAbs Therapeutics, Inc. | 1.37% |
18 | EXEL | Exelixis, Inc. | 1.37% |
19 | IBRX | ImmunityBio, Inc. | 1.36% |
20 | MOR | MorphoSys AG | 1.36% |
21 | FHTX | Foghorn Therapeutics Inc. | 1.36% |
22 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35% |
23 | HCM | HUTCHMED (China) Limited | 1.35% |
24 | INBX | Inhibrx, Inc. | 1.35% |
25 | STRO | Sutro Biopharma, Inc. | 1.34% |
26 | BPMC | Blueprint Medicines Corporation | 1.34% |
27 | AURA | Aura Biosciences, Inc. | 1.32% |
28 | IPHA | Innate Pharma S.A. | 1.32% |
29 | GMAB | Genmab A/S | 1.32% |
30 | RAPT | RAPT Therapeutics, Inc. | 1.32% |
31 | SDGR | Schrödinger, Inc. | 1.31% |
32 | BCYC | Bicycle Therapeutics plc | 1.30% |
33 | PGEN | Precigen, Inc. | 1.29% |
34 | SNDX | Syndax Pharmaceuticals, Inc. | 1.28% |
35 | DCPH | Deciphera Pharmaceuticals, Inc. | 1.27% |
36 | REGN | Regeneron Pharmaceuticals, Inc. | 1.27% |
37 | BNTX | BioNTech SE | 1.26% |
38 | ERAS | Erasca, Inc. | 1.26% |
39 | VOR | Vor Biopharma Inc. | 1.26% |
40 | BMY | Bristol-Myers Squibb Company | 1.25% |
41 | IDYA | IDEAYA Biosciences, Inc. | 1.25% |
42 | ZNTL | Zentalis Pharmaceuticals, Inc. | 1.24% |
43 | MRUS | Merus N.V. | 1.23% |
44 | IGMS | IGM Biosciences, Inc. | 1.23% |
45 | APLM | Apollomics, Inc. | 1.23% |
46 | IMCR | Immunocore Holdings plc | 1.21% |
47 | SWTX | SpringWorks Therapeutics, Inc. | 1.19% |
48 | RCUS | Arcus Biosciences, Inc. | 1.18% |
49 | IMTX | Immatics N.V. | 1.18% |
50 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.17% |
As of Apr 16, 2024